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BLOOD VOLUME CHANGES 
P h i l i p  C. Johnson, M. D. *, Theda B. DriscoZZ" 
and Adrian D. LeBZanee, Ph. D. * 
ABSTRACT 
Analysis of radionucl ide volume determinations made f o r  the crewmembers 
of selected Gemini and Apollo missions showed tha t  orb i ta l  spaceflight 
has an e f f ec t  on red ce l l  mass. 
developed for  e a r l i e r  f l i g h t s  were used fo r  the crews of the three 
Skylab missions, d i r ec t  comparisons are  possible. After each Skylab 
mission, decreases were found i n  crewmembers' red ce l l  masses. The 
mean red cel l  mass decrease of 11 percent o r  232 m i l l i l i t e r s  was 
approximately equal t o  the 10 percent mean red ce l l  mass decrease of 
the Apollo 14 t o  17 crewmembers. 
The red cel l  ,mass drop was greatest  and the postrecovery reticulocyte 
response l e a s t  f o r  crewmembers of  the 28-day Skylab 2 mission. Analy- 
ses of data from the red cel l  mass determinations indicate tha t  the red 
cel l  mass drops occurred i n  the f i r s t  30 days of f l i g h t  and tha t  a 
gradual recovery of the red ce l l  mass de f i c i t s  began approximately 
60 days a f t e r  launch. The beginning of red cel l  mass regeneration 
d u r i n g  the Skylab 4 f l i g h t  may explain the higher postmission 
reticulocyte counts. 
Because the methods and the protocol 
INTRODUCTION 
Decreased red ce l l  mass has been found regularly among astronauts who 
return from space f l i g h t .  
the 8-day Gemini 5 mission and confirmed i n  the crewmembers of  the 
14-day Gemini 7 mission. 
halftimes were shortened suggesting hemolysis combined w i t h  a bone 
marrow unresponsive t o  the decrease were the major causes of the 
observed decrease i n  red ce l l  mass (1) .  Similar s tud ie s t a f t e r  four 
Apollo moon landing missions showed hat the red ce l l  mass decreases 
suggesting t h a t  marrow inhibi t ion rather than hemolysis may have 
been the cause of the 10 percent mean red cel l  mass loss .  
both the Apollo and Gemini missions were exposed t o  a t  l ea s t  four 
hours of 100 percent oxygen a t  760&torr  (1.0132 X lo5 N/m2)  p r ior  t o  
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This was f i r s t  documented i n  the crew of 
Simultaneously estimated 51Cr red blood cel l  
were not associated w i t h  decreased 5t: Cr red blood ce l l  survivals 
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launch and d u r i n g  f l i g h t  t o  a hypobaric-hyperoxic atmosphere [lo0 per- 
cent oxygen, 258 t o r r  (0.3440 X lo5 N / m 2 ) ] .  
explain the decrease in red cell  mass as due to  the e f fec ts  of hyper- 
oxia since hyperoxia is  known to b o t h  inh ib i t  erythropoiesis and 
cause hemolysis (2,3).  
I t  has been tempting to  
The Skylab missions d i f f e r  from the Apollo missions by not having 
hyperoxic environment except for  two hours of 100 percent oxygen a t  
760 to r r  (1.0132 X lo5 N/m2) prior to  launch and for  a few hours d u r i n g  
the f i r s t  day when the atmosphere was similar t o  tha t  of Apollo. 
Skylab missions have afforded an opportunity to  rule  out the hyperoxic 
hypothesis of the red ce l l  mass decrease while a t  the same time 
tes t ing whether changes i n  red ce l l  mass are  progressive with longer 
periods i n  weightlessness. 
The 
METHODS 
Red cell  mass measurements were made according t o  the following 
schedule. 
recovery day and 13, 42 and 67 days l a t e r ;  Skylab 3, a 59-day mission: 
20 days before launch, recovery day and 14 and 45 days l a t e r ;  and 
Skylab 4,  an 84-day mission: 21 and 1 day before launch, recovery 
day and 14 and 31 days l a t e r .  All specimens were drawn i n  the morning 
a f t e r  an overnight rest w i t h  the crewman fasting except for  the 
recovery day samples which were drawn w i t h i n  two hours of the time when 
the spacecraft landed in the ocean. 
for the red cel l  mass was mixed w i t h  2.5 m i l l i l i t e r s  of special ACD 
solution and 25 VCi 51Cr. Sixty m i l l i l i t e r s  of blood to  sa t i s fy  the 
blood requirements of other experiments was drawn prior to  the rein- 
fusion of the 10 m i l l i l i t e r s  of the 51Cr tagged red c e l l s .  
were incubated for  four minutes a t  room temperature and subsequently 
14 milligrams of ascorbic acid was added prior t o  reinfusion. 
ce l l  mass determination was obtained by averaging the red cel l  
radioactivity of a 30- and 31-minute sample. 
2.5 m i  11 i 1 i ters of bl ood was drawn. 
to  remove the e f fec t  of untagged chromium. 
accurate injection and s t a t i s t i c a l 1  
ac t iv i ty  a re  described elsewhere (4 Y s 
Thirty days pr ior  to  launch, 50 V C i  14C-glycine was injected intra-  
venously for  a red ce l l  l i f e  span study; the 14C radioactivity was 
followed for  a total  of 125 days on the f i r s t  mission, 131 days on 
the second mission, and 141 days on the t h i r d  mission. Blood was 
generally drawn weekly t h r o u g h o u t  this period including the time i n  
space. Radioactivity was determined by extracting heme, i g n i t i n g  
the dried extract  and determining V C i  of 1% per milligram heme. A t  
Skylab 2 ,  a 28-day mission: 29 days prior t o  launch, 
The 12.5 m i l l i l i t e r s  of blood drawn 
The c e l l s  
The red 
For each specimen, 
P1 asma radioactivity was separated 
s ignif icant  counting of the radio- 
The methods used to  assure 
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recovery, 2 WCi of 59Fe c i t r a t e  was injected fo r  calculation of iron 
turnover using the 30-, 31-minute samples and a blood sample drawn 2 
t o  3 hours l a t e r .  Iron reappearance was obtained from blood samples 
drawn 1 ,  3, 7 ,  and 14 days a f t e r  recovery. Reticulocyte counts were 
obtained weekly pref l ight  and postmission. Activity of 51Cr red ce l l s  
was measured to  estimate red ce l l  chromium halftime. The  total  blood 
drawn fo r  each crewmember i s  shown i n  table I .  
TABLE I .  BLOOD DRAWN FOR SKYLAB CREW MEMBERS AND CONTROL SUBJECTS 
Mission D u r i n g  Mean 
Duration Preflight F1 ight Postfl ight Total* mllday 
(Days) m l  /days ml /days ml /days m l  /days ml 
28 3851 30 44/28 36511 8 794176 10 
59 3441 2 1 881 59 373120 8051 1 00 8 
84 378135 88/84 423121 88911 40 6 
*Total m i l l i l i t e r s  blood/days between f i r s t  and l a s t  blood draw. 
No single blood specimen exceeded 100 m i  11 i 1 i t e r s  i n  any 24-hour 
period . 
To insure tha t  the amount of blood drawn d i d  not influence these re- 
s u l t s ,  similar amounts of blood were drawn from healthy control sub- 
j ec t s .  These control subjects were approximately the same age as the 
crewmembers. Since the control subjects accompanied the medical team 
to the recovery car r ie rs  and Cape Kennedy, their blood resul ts  were a 
confirmation tha t  the remote f a c i l i t i e s  and delayed final preparation 
d i d  not a f fec t  the resu l t s .  
RESULTS 
Table I1 shows the red cel l  mass volume values obtained from the nine 
crewmembers and the nine control subjects. These a re  presented as 
total  red cel l  mass ( m i l l i l i t e r s )  and on a m i l l i l i t e r s  per kilogram 
body weight basis. 
The  mean value of the premission red ce l l  mass o f  the crewmembers was 
2075 m i l l i l i t e r s  which is  not different  from the mean values of the 
controls, 2053 m i l l i l i t e r s .  The mean values o f  the red ce l l  masslkilo- 
grams body weight was 28.9 mill i l i tesslkilogram fo r  the crew and 
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27.2 milliliters/kilogram for the controls. These mean values are not 
different statistically. 
1843 milliliter 
different from 
(P = <0.05). The cre 
liters and the contro 
on a milliliters/kilogram body weight basis, the crew's postmission 
mean value was 26.6 milliliters/kilogram body weight or 2.3 milliliters 
less than premission w5ile the controls did not change from the pre- 
mission value of 27 milliliters/kilogram body weight. 
Evidence against a hemolytic process is presented in table I11 where 
the 51Cr red cell T% pre 
14C-glycine red cell lif 
difference of statistical significance between the preflight and post- 
fligh crew mean values or the crew and control mean values either for 
the 5fCr Tk or the 14C-glycine red cell mean life span. 
The recovery mean value of 
ght and postmission values and the * 
pan mean values are shown. There is no 
Tab1 e IV shows the iron turnover results . The 0.32 mi 11 i 1 i ters/ki logram 
body weight per day for the crew is similar to the 0.30 milliliters/ 
kilogram body weight per day for the control subjects. Statistical 
analysis indicates no difference between controls and crew in re- 
appearance or turnover indicating that the rate of erythropoiesis was 
essentially the same for crewmembers and control subjects. 
Table V shows the reticulocyte counts arranged according to mission. 
These are shown as the number of reticulocytes per cubic milliliters 
of blood X 10-3. 
covery following each mission. 
than premission means were found in only ode crewmember of the 28-day 
mission at 2 weeks, the 3 crewmembers of the 59-day mission at 1 week, 
and 1 week or less for the 84-day mission's crew. 
indicate that red cell mass regeneration did not occur until fourteen 
or more days after recovery from the shortest mission. The control 
subjects did not develop a change in the reticulocyte count at any 
time indicating that reticulocyte changes found in the crewmembers were 
not caused by the blood drawing schedule. 
The reticuoctye counts were low when drawn at re- 
Postmission reticulocyte counts greater 
These results 
DISCUSSION 
The red cell mass results of the Skylab studies show that the crewmembers 
sustained a statistically significant decrease in circulating red cells. 
The decreases were not found among the ground-based control subjects 
indicating that the blood drawn for the extensive metabolic studies 
did not cause the change. Additionally, the second red cell mass 
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TABLE 111. 
M i  s s i  on 
Dura t ion  
(Days 1 
28 
59 
84 
MEAN 
2S.E. 
28 
59 
84 
MEAN 
+S.E. 
RED CELL HALFTIMES IN DAYS OF SKYLAB CREWMEMBERS 
AND CONTROL SUBJECTS 
Crewmembers Cont ro ls  
Post- Post- 
P r e f l  i gh t  F1 i g h t  Change P r e f l  i g h t  F1 i ght  
31.2 24.2 -7.0 23.8 23.3 
26.6 21.7 -4.9 24.7 23.0 
27.9 24.4 -3.5 23.1 21 .o 
24.4 22.8 -1.6 26.4 22.0 
28.8 27.2 -1.6 21.5 22.0 
25.6 23.6 -2.0 24.0 23.2 
24.4 27.4 +3.0 29 .O 26.7 
22.7 24.5 +1.8 25.6 24.8 
23.5 21.8 -1.7 20.0 20.1 
26.1 24.2 -1.9 24.2 22.9 
kO.7 k l .0 kO.9 50.7 20.9 
14C-GLYCINE RED CELL MEAN LIFE SPAN I N  DAYS 
Crewmembers 
130 
117 
116 
128 
122 
122 
125 
131 
113 
123 
+2 
500 
Cont ro ls  
- 
- 
- 
116 
122 
107 
1 30 
128 
106 
121 
+4 
Change 
-0.5 
-1.7 
-2.1 
-4.4 
+0.5 
-0.8 
-2.3 
-0.8 
+0.1 
-1.3 
k0.5 
TABLE IV. IRON TURNOVER 
Mission Duration (ml/kg body w e i g h t  per day) 
(Days) C rewrnembe rs Controls 
28 
59 
84 
0.22 
0.35 
0.38 
0.39 
0.24 
0.21 
0.30 
0.38 
0.42 
0.38 
0.33 
0.35 
0.29 
0.30 
0.29 
0.21 
0.23 
0.32 
MEAN 0.32 G.30 
rtS.E. rt0.03 20.01 
obtained from the crew prior to  the 84-day mission showed that  no de- 
crease i n  red ce l l  mass occurred prior t o  launch indicating tha t  pre- 
mission preparations d i d  n o t  cause the change. 
post recovery was normal. The depressed reticulocyte counts a t  re- 
covery indicate inhibited reticulocyte release or accelerated loss of 
re t icu lar  material. The lowering of reticulocyte counts was greatest  
for  the crew of the shortest  mission and l eas t  fo r  the crew o f  the 
longest mission. T h i s  suggests the 84-day crew may already have been 
in the recovery or  replacement phase of red cel l  mass prior t o  their 
return from weightlessness. 
the 28-day Skylab mission was greater than the mean resul ts  obtained 
from the Apollo crewmembers while the mean decrease found a f t e r  the 
longest Skylab mission was less  ( 5 ) .  
Iron turnover immediately 
The red cel l  mass mean decrease found a f t e r  
The etiology of the red cell  mass drop and lowered reticulocyte counts 
a t  recovery is  unknown. The red cell  mass is the most s table  of the 
various blood constituents. 
due to  hemorrhaging or  hemolysis. Gradual decreases a re  produced by 
inhibit ion of bone marrow ac t iv i ty ,  ineffective erythropoiesis or chronic 
hemorrhage. There was no cl inical  evidence of hemorrhage among the 
crews and haptoglobin levels have tended t o  be normal or elevated 
rather than suppressed indicating tha t  intravascular hemolysis d i d  n o t  
occur i n  Apol 10 or  Skylab crews (6 ) .  
c l in ica l  evidence to  suggest ineffective erythropoiesis. The low reticu- 
locyte counts a re  additional evidence against ineffective erythropoiesis. 
Sudden drops i n  red ce l l  mass a re  possible 
Iron reappearance data gave no 
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An age dependent loss of red ce l l s  i s  a possibi l i ty  and would not be 
seen i n  the survival curves obtained i f  red ce l l s  greater than 30 days 
of age were sequestrated and destroyed selectively d u r i n g  the 
few mission days. Loss of c e l l s  older than 30 days would not 
the resul ts  since the older cel l  d i d  n o t  contain the 14C-glycine. 
Premature loss of older ce l l s  without intravascular hemolysis suggests 
red cel l  surface and shape changes. This was actually found since a l l  
crewmembers showed an increase i n  abnormal red ce l l  shapes including 
crenated erythrocytes i n  the scanning electron microscope evaluation 
of their blood samples taken a t  the end of the f l i g h t  ( 7 ) .  Hyperoxia 
through l i p i d  peroxidation could cause the red ce l l  shape changes. 
T h i s  may have been the cause of the red ce l l  mass decreases found i n  
Gemini and Apollo crewmembers. I t  could n o t  explain the red cel l  
mass decrease noted i n  the Skylab crewmembers. Therefore, other 
aspects of the environment must have caused this change. A possible 
b u t  unproven explanation of  this combination of abnormally shaped 
red c e l l s  and decreased red cell  mass among the Skylab astronauts 
would be a change i n  splenic function d u r i n g  the mission. Hyper- 
splenism could s t a r t  early d u r i n g  the mission when the blood volume 
was relat ively too large perhaps associated w i t h  the increased portal 
pressure and/or decreased portal flow. T h i s  would be consistent w i t h  
the two or three days of nausea and loss of appetite reported by sus- 
ceptible crewmembers. 
The crewmembers ' reticulocyte counts were low a t  recovery indicating 
increased splenic removal of reticulum or decreased bone marrow 
production rates .  A vitamin E deficiency i s  one cause of early 
reticulum loss ,  b u t  inhibited bone marrow i s  more l ikely because the 
red ce l l  mass stayed low. Bone marrow function would not increase t o  
replace the l o s t  red ce l l s  i f  oxygen delivery to  the kidney was main- 
t a i  ned. 
s h i f t i n g  the oxygen disassociation curve to  the r i g h t .  
net oxygen delivery to  the t issues i s  increased making a lowered red 
cel l  mass adequate fo r  tissue oxygen (8).  
account for  the Skylab results since i n - f l i g h t  blood specimens showed 
higher phosphorus levels.  The red cel l  mass decrease associated w i t h  
space f l i g h t  i s  not followed by a decrease i n  hemoglobin concentration 
since plasma volume decreases occur a t  the same time (5 ) .  The  kidneys 
use both changes i n  hemoglobin concentration and oxygen delivery to  
modulate erythropoietin release. T h u s ,  the decreased red cel l  masses 
o f  the Skylab crewmembers m i g h t  not be followed by compensatory i n -  
creases i n  erythropoietin until  plasma volume increased. Without 
increased erythropoietin, bone marrow ac t iv i ty  would not increase and 
should appear i n h i b i t e d  u n t i l  a new equilibrium is reached. 
E i  ther hyperoxi a or hyperphosphatemi a could cause this by 
In this way 
This mechanism helps 
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B o t h  hyperphosphatemia and the decreased plasma volume seem t o  explain 
the low reticulocyte counts found a t  recovery. A t  recovery iron 
turnover was normal indicating a possible rebound i n  bone marrow 
act ivi ty .  The rapid expansion i n  plasma volume during tha t  time 
could account fo r  the normal i ron turnover. 
Taken in i t s  t o t a l i t y  with previous f l i g h t  data, the Skylab data 
confirm tha t  a decrease i n  red ce l l  mass is  a constant occurrence 
in space f l i g h t .  Except i n  the Gemini missions the decrease does not 
seem t o  be caused by intravascular hemolysis. 
red ce l l s  i s  a plausible explanation f o r  the loss of red c e l l s .  
the i n i t i a l  loss, there is  a t  l ea s t  a 30-day delay before the red 
ce l l  mass begins to  reconsti tute i t s e l f  indicating an i n h i b i t e d  bone 
marrow. Bone marrow function i s  i n h i b i t e d  because the decrease i n  
red ce l l  mass i s  associated w i t h  a decrease i n  plasma volume and 
increased plasma phosphorus levels. 
explains the observed decrease i n  reticulocyte counts. 
Splenic trapping of 
After 
T h i s  combination probably 
REFERENCES 
1 .  Fischer, C. L . ,  P .  6. Johnson, and C .  A .  Berry. 1967. Red blood 
ce l l  mass and plasma volume changes i n  manned space f l i g h t .  
JAMA, ZOO,  pp .  99-203. 
2 .  Mengel, 6. E . ,  H .  E .  Kann, J r . ,  A .  Heyman, and E .  Metz. 1965. 
Effects of i n  vivo hyperoxia on erythrocytes. 11. Hemolysis 
in a human a f t e r  exposure t o  oxygen under h i g h  pressure. BZood, 
25, pp. 822-829. 
3 .  Larkin, E .  C . ,  J .  D .  Adams, W .  T. Williams, and D .  M. Duncan. 
1972. Hematologic responses t o  hypobaric hyperoxia. Am. J .  
PhysioZ., 79, pp. 541-549. 
4. Johnson, P .  C . ,  T. B. Driscoll, and C .  L .  Fischer. 1971. Blood 
volume changes i n  divers of Tektite I .  Aerospace Med., 42, 
pp. 423-426. 
5. Johnson, P .  C . ,  S. L .  Kimzey, and T.  9. Driscoll . Postmission 
plasma volume and red cell mass changes i n  the crews of the f i r s t  
two Skylab missions. Astronautica Acta (In Press). 
6. Fischer, C .  L ,  C .  G i l l ,  J .  C .  Daniels, E.  K. Cobb, 6. A. Berry, 
and S. E .  Ritzmann. 1972. Effects of the space f l i g h t  environ- 
ment on man's immune system: 1 .  Serum proteins and immunoglobulins. 
Aerospace Med., 43, pp. 856-859. 
504 
7.  Kimzey, S .  L . ,  L .  C .  Burns, and C. L. Fischer. Experiment M115-- 
Special Hematologic effects :  Dynamic changes i n  red ce l l  shape 
i n  response to  the space f l i gh t  environment. 
Skylab Life Sciences Symposium, August 27-29, 1974, Lyndon B. 
Johnson Space Center, Houston, Texas. 
Presented a t  the 
8. Lichtman, M .  A . ,  D. R.  Miller, and R .  I .  Weed. 1969. Energy 
metabolism i n  uremic red ce l l s :  Relationship of red ce l l  . 
adenosine triphosphate concentration to  extracel lular  phosphate. 
Tpans. of Associa. of Amer. Physicians, 82, pp .  331-343. 
505 
